These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1465818

  • 1. Kidney transplantation in Slovenia from 1986 through 1991.
    Kandus A, Buturović-Ponikvar J, Malovrh M, Bren AF.
    Transplant Proc; 1992 Dec; 24(6):2430-1. PubMed ID: 1465818
    [No Abstract] [Full Text] [Related]

  • 2. Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy.
    Keitel E, Bittar AE, Losekann A, Deboni L, Ceretta F, Goldani JC, Garcia VD.
    Transplant Proc; 1992 Dec; 24(6):2606-8. PubMed ID: 1465881
    [No Abstract] [Full Text] [Related]

  • 3. Measures to improve early results in kidney transplantation.
    Schweizer RT, Roper L, Hull D, Bartus S.
    Transplant Proc; 1992 Dec; 24(6):2729-30. PubMed ID: 1465919
    [No Abstract] [Full Text] [Related]

  • 4. Low-dose OKT3 for cadaveric renal transplantation.
    Schweizer RT, Roper L, Hull D, Bartus SA.
    Transplant Proc; 1992 Dec; 24(6):2592-3. PubMed ID: 1465875
    [No Abstract] [Full Text] [Related]

  • 5. DR6 compatibility and kidney graft survival.
    Correia AM, de Costa AG, Reis P, Rego F, Sampaio MJ, Caetano JM, Pena JR.
    Transplant Proc; 1992 Dec; 24(6):2472. PubMed ID: 1465836
    [No Abstract] [Full Text] [Related]

  • 6. Value of monoclonal antibody OKT3 in solid organ transplantation: a meta-analysis.
    Carrier M, Jenicek M, Pelletier LC.
    Transplant Proc; 1992 Dec; 24(6):2586-91. PubMed ID: 1465874
    [No Abstract] [Full Text] [Related]

  • 7. Cardiovascular effects of ATG and OKT3 in renal allograft recipients.
    Spieker C, Barenbrock M, Buchholz B, Heidenreich S, Zidek W.
    Transplant Proc; 1992 Dec; 24(6):2594-5. PubMed ID: 1465876
    [No Abstract] [Full Text] [Related]

  • 8. Azathioprine can be safely stopped in triple drug induction protocols including cyclosporine and steroids in renal transplantation.
    Pallardó LM, Sánchez J, Sánchez P, García J, Orero E, Beneyto I, Ros F.
    Transplant Proc; 1992 Dec; 24(6):2604-5. PubMed ID: 1465880
    [No Abstract] [Full Text] [Related]

  • 9. Analysis of risk factors affecting the outcome of primary living donor renal transplantation in Korea.
    Park K, Kim YS, Kim SI.
    Transplant Proc; 1992 Dec; 24(6):2426-7. PubMed ID: 1465816
    [No Abstract] [Full Text] [Related]

  • 10. Repeated HLA mismatch in multiple kidney transplantation: preliminary results of 146 retransplantations in the cyclosporine era.
    Gnant MF, Sautner T, Rosenmayr A, Muehlbacher F.
    Transplant Proc; 1992 Dec; 24(6):2466-8. PubMed ID: 1465833
    [No Abstract] [Full Text] [Related]

  • 11. Role of maintenance immunosuppression and methylprednisolone in OKT3-induced cytokine release.
    Peces R, Urra JM, Gorostidi M, López-Larrea C.
    Transplant Proc; 1992 Dec; 24(6):2596-9. PubMed ID: 1465877
    [No Abstract] [Full Text] [Related]

  • 12. Enhanced renal graft survival in HLA-A mismatched transplants.
    Bućin D, Ekberg H, Lindholm A, Persson H, Tufvesson G, Albrechtsen D.
    Transplant Proc; 1992 Dec; 24(6):2473-4. PubMed ID: 1465837
    [No Abstract] [Full Text] [Related]

  • 13. Importance of certain HLA-A,B haplotypes for the survival of renal grafts from living-related donors.
    Polymenidis Z, Adam K, Parapanissiou E, Sakellariou G, Papakyriazi E, Antoniadis A, Papadimitriou M.
    Transplant Proc; 1992 Dec; 24(6):2458-60. PubMed ID: 1465830
    [No Abstract] [Full Text] [Related]

  • 14. Repeated mismatches may not impair survival of renal regrafts in recipients with 0% to 50% panel reactive antibodies.
    Mjörnstedt L, Konar J, Skarp I, Olausson M, Sandberg L, Tufvesson G.
    Transplant Proc; 1992 Dec; 24(6):2469. PubMed ID: 1465834
    [No Abstract] [Full Text] [Related]

  • 15. Negative crossmatch on current sera and good HLA matching are the main requirements for renal transplantation in highly sensitized patients.
    Cristol JP, Mourad G, Argiles A, Seignalet J, Iborra F, Ramounau-Pigot A, Chong G, Mion C.
    Transplant Proc; 1992 Dec; 24(6):2470-1. PubMed ID: 1465835
    [No Abstract] [Full Text] [Related]

  • 16. Living-unrelated renal transplantation.
    Simforoosh N, Bassiri A, Amiransari B, Gol S.
    Transplant Proc; 1992 Dec; 24(6):2421-2. PubMed ID: 1465814
    [No Abstract] [Full Text] [Related]

  • 17. Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors.
    Pallardó LM, Sánchez P, Sánchez J, García J, Orero E, Beneyto I, Cruz JM.
    Transplant Proc; 1992 Dec; 24(6):2714-5. PubMed ID: 1465911
    [No Abstract] [Full Text] [Related]

  • 18. Influence of recipient's HLA type on the outcome of renal transplantation.
    Forsberg B, Ekberg H, Johnson U.
    Transplant Proc; 1992 Dec; 24(6):2463-5. PubMed ID: 1465832
    [No Abstract] [Full Text] [Related]

  • 19. Influence of HLA antigens of renal transplant recipients on graft survival.
    Alamartine E, Berthoux F, Acquart S, Lepetit JC.
    Transplant Proc; 1992 Dec; 24(6):2461-2. PubMed ID: 1465831
    [No Abstract] [Full Text] [Related]

  • 20. Influence of HLA matching on the outcome of kidney transplants in a single center analysis.
    Schanz D, Blümke M, Keller E, Tanzi-Fetta RF, Kirste G.
    Transplant Proc; 1992 Dec; 24(6):2455. PubMed ID: 1465828
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.